Total Funding
30
56
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
221727
BIDEA develops point-of-care in-vitro diagnostic devices for the early detection of endometrial cancer.
About the Company
BIDEA offers tests that will not only impact the quality of life of patients but can also reduce costs to hospitals, health insurance companies, and government agencies. Their proposed screening technology is expected to help gynaecologists in hospitals and in private practices provide a complete diagnosis in less time, reducing the number of
visits and endometrial cancer incidence through early detection, especially in women over the age of 50.
